Pages that link to "Q37214501"
Jump to navigation
Jump to search
The following pages link to Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system (Q37214501):
Displaying 50 items.
- The rise of regulatory RNA (Q22121998) (← links)
- CRISPR-Cas9 Genome Editing in Drosophila (Q26314632) (← links)
- Methods of Genome Engineering: a New Era of Molecular Biology (Q26741958) (← links)
- Diversity of CRISPR-Cas-Mediated Mechanisms of Adaptive Immunity in Prokaryotes and Their Application in Biotechnology (Q26741960) (← links)
- Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology (Q26742051) (← links)
- Recent Advances in Genome Editing Using CRISPR/Cas9 (Q26744073) (← links)
- Genome Engineering with TALE and CRISPR Systems in Neuroscience (Q26752488) (← links)
- Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future (Q26753206) (← links)
- Emerging Technologies to Create Inducible and Genetically Defined Porcine Cancer Models (Q26765901) (← links)
- Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain (Q26770355) (← links)
- Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome (Q26771497) (← links)
- Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation (Q26775746) (← links)
- Resources for the design of CRISPR gene editing experiments (Q26776435) (← links)
- Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools (Q26777286) (← links)
- Applications of DNA integrating elements: Facing the bias bully (Q26781121) (← links)
- A new age in functional genomics using CRISPR/Cas9 in arrayed library screening (Q26781135) (← links)
- Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research (Q26781399) (← links)
- Enabling functional genomics with genome engineering (Q26782747) (← links)
- Strategies for precision modulation of gene expression by epigenome editing: an overview (Q26782876) (← links)
- The New State of the Art: Cas9 for Gene Activation and Repression (Q26787037) (← links)
- Origins, genetic landscape, and emerging therapies of small cell lung cancer (Q26798218) (← links)
- Genome-editing tools for stem cell biology (Q26800186) (← links)
- Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference (Q26852489) (← links)
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering (Q26859390) (← links)
- Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues (Q26998879) (← links)
- A CRISPR method for genome engineering (Q27000786) (← links)
- Making designer mutants in model organisms (Q27010108) (← links)
- RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes (Q27025675) (← links)
- Considerations when investigating lncRNA function in vivo. (Q27691450) (← links)
- The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases (Q28085767) (← links)
- Genome editing. The new frontier of genome engineering with CRISPR-Cas9 (Q28252298) (← links)
- CRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjection (Q28830781) (← links)
- CRISPR-Cas systems for editing, regulating and targeting genomes (Q29615781) (← links)
- Cas9-chromatin binding information enables more accurate CRISPR off-target prediction. (Q30279249) (← links)
- A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans (Q30586090) (← links)
- A protein-tagging system for signal amplification in gene expression and fluorescence imaging (Q30604320) (← links)
- Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA. (Q33558320) (← links)
- Genome engineering of stem cell organoids for disease modeling (Q33628093) (← links)
- Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. (Q33704483) (← links)
- Genetic and epigenetic control of gene expression by CRISPR-Cas systems (Q33777855) (← links)
- Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. (Q33830378) (← links)
- ZNF300 tight self-regulation and functioning through DNA methylation and histone acetylation (Q33850906) (← links)
- Regulatory Roles of Long Non-Coding RNAs in the Central Nervous System and Associated Neurodegenerative Diseases (Q33855574) (← links)
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing (Q33875102) (← links)
- Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. (Q33901103) (← links)
- Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells (Q34039369) (← links)
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. (Q34043681) (← links)
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders (Q34045672) (← links)
- CRISPR/Cas9 in allergic and immunologic diseases (Q34047460) (← links)
- Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells (Q34093413) (← links)